The company anticipates sales of $313.6 million, up 7.9 percent from last year’s $290.5 million in net sales. Preliminary fourth quarter sales for the company’s surgical implants business grew 22.2 percent over the fourth quarter of 2012.
More Articles on Devices:
Device Companies — 6 Key Notes — NuVasive, Aurora Spine & More
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
